There have been previous studies evaluating potential biomarkers for ACS, including secretory phospholipase A2 (sPLA2), endothelin-1, interleukin-6, and peripheral white blood cell count [28]. The gene discussed is PLA2G2D; the disease is acute chest syndrome.